The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVenn Life Sciences Share News (VENN)

  • There is currently no data for VENN

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK Shareholder Meetings Calendar - Next 7 Days

Wed, 20th Jun 2018 16:09

Thursday 21 June
HSS Hire Group
Friday 22 June
Cambian Group
boohoo.com
Next Fifteen Communications Group
Braemar Shipping Services
Monday 25 June
Asiamet Resources
Coro Energy
Augean
TLA Worldwide
Windar Photonics
Telit Communications
JKX Oil & Gas
Rasmala
Pelatro
United Oil & Gas
ITE Group (re acquisition of Ascential Events)
Standard Life Aberdeen (re sale of Standard Life Assurance to Phoenix)
Tuesday 26 June
Capita
Faroe Petroleum
Marwyn Value Investors
Morses Club
Griffin Mining
Universe Group
LXI REIT
Surgical Innovations Group
Wednesday 27 June
Whitbread
Rockrose
Animalcare Group
Shield Therapeutics
Crawshaw Group
Atalaya Mining
Watchstone Group
Kore Potash
Venn Life Science
Wentworth Resources
RELX (re simplification of corporate structure)
 

More News
23 Oct 2015 08:17

Venn Life Sciences signs EUR1m contract

(ShareCast News) - Venn Life Sciences has signed a €1m contract with a leading French biotech company. The AIM listed clinical research organisation announced the deal on Friday. The two-phase project is centred on acute T-cell leukaemia, and will cover multiple regions including France, the UK and

Read more
23 Oct 2015 06:42

Venn Life Sciences Wins Leukaemia Project Worth Over EUR1 Million

Read more
19 Oct 2015 07:12

Venn Life Sciences Appoints Kinesis Pharma's Groen Executive Director

Read more
22 Sep 2015 15:51

Venn Life posts narrow interim loss, acquires Kinesis

(ShareCast News) - Clinical trial services provider Venn Life Sciences posted a narrower interim pre-tax loss and has agreed to acquire Kinesis Pharma BV. In the six months to the end of June, the London-listed company saw its pre-tax loss narrow from €987,000 (£716,000) to €259,000, while revenue a

Read more
22 Sep 2015 08:35

Venn Life Sciences To Buy Kinesis Pharma As Interim Loss Narrows (ALLISS)

Read more
13 Aug 2015 11:35

Venn Life Sciences reports strong first-half trading

(ShareCast News) - Venn Life sciences said it has had a strong first half, with revenues up 170% on the previous year. In a very brief trading update, the company, which provides clinical trial management and resourcing solutions to pharmaceutical, biotechnology and medical device clients, reported

Read more
13 Aug 2015 06:45

Venn Life Sciences Says Strong First Half Driven By Contract Wins

Read more
30 Jun 2015 08:31

Venn Life Sciences Sees "Further Solid Trading" In First Half

Read more
30 Jun 2015 07:31

LONDON BRIEFING: Shares Ignore Positive Asian Session To Open Lower

Read more
30 Jun 2015 05:16

AGM, EGM Calendar - Week Ahead

Read more
29 Jun 2015 15:11

AGM, EGM Calendar - Week Ahead

Read more
29 Jun 2015 05:21

AGM, EGM Calendar - Week Ahead

Read more
26 Jun 2015 15:13

AGM, EGM Calendar - Week Ahead

Read more
26 Jun 2015 05:20

AGM, EGM Calendar - Week Ahead

Read more
25 Jun 2015 15:30

AGM, EGM Calendar - Week Ahead

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.